(Q39172192)

English

Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis

scientific article published on 29 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

based on heuristic

inferred from title

squamous cell carcinoma

1 reference

based on heuristic

inferred from title

tongue squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Zicheng Wei

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Yanling Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Zhongwu Li

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Chunping Yuan

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Wei Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Dongmiao Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Jinhai Ye

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Hongbin Jiang

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Yunong Wu

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Jie Cheng

10

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

29 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Journal of Oral Pathology & Medicine

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

747-754

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

Head and neck cancer

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

Recent advances in oral oncology 2008; squamous cell carcinoma imaging, treatment, prognostication and treatment outcomes

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I).

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II).

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

The hippo signaling pathway in development and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene.

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

YAP is a candidate oncogene for esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

TAZ, a transcriptional modulator of mesenchymal stem cell differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

TAZ is a novel oncogene in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

TEADs mediate nuclear retention of TAZ to promote oncogenic transformation

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

Characteristics of a cancerous cell line, HIOEC-B(a)P-96, induced by benzo(a)pyrene from human immortalized oral epithelial cell line

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

FRMD4A upregulation in human squamous cell carcinoma promotes tumor growth and metastasis and is associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

The hippo pathway

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

TAZ-mediated crosstalk between Wnt and Hippo signaling.

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

Prognostic significance of TAZ expression in resected non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJOP.12062

21 January 2018

Identifiers

10.1111/JOP.12062

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39172192&oldid=1811644656"